Top

Reactions Weekly

Published in:

01-10-2022 | Tadalafile | Case report

Treprostinil

Site pain, drug ineffectiveness and lack of efficacy: 3 case reports

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Colglazier E, et al. Safety and tolerability of a rapid transition from intravenous treprostinil to oral selexipag in three adolescent patients with pulmonary arterial hypertension. Journal of Pediatric Pharmacology and Therapeutics 26: 512-516, No. 5, 2021. Available from: URL: https://doi.org/10.5863/1551-6776-26.5.512

Title: Treprostinil
Site pain, drug ineffectiveness and lack of efficacy: 3 case reports
Publication date: 01-10-2022
Publisher: Springer International Publishing
Keywords: Tadalafile
Ambrisentan
Arterial Hypertension
Arterial Hypertension
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-26785-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Treprostinil

Site pain, drug ineffectiveness and lack of efficacy: 3 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Gefitinib

Antineoplastics

Aspirin/tirofiban

Azd-1222/bbv-152

Multiple drugs

Multiple drugs